Type 2 Diabetes Trial, Recruiting NCT05026723 Sponsor: University of North Carolina, Chapel Hill Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05026723
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any gender are eligible.
  • People who have been diagnosed with HIV.
  • People who have been diagnosed with Type 2 Diabetes, OR people who are at high risk of developing Type 2 Diabetes — meaning they meet at least one of these conditions: a recent blood test showing blood sugar levels in the prediabetes range, a previous diagnosis of gestational diabetes (diabetes during pregnancy), or a score of 5 or higher on the CDC's Prediabetes Risk Test.
  • People who are currently experiencing food insecurity, as measured by a standard two-question screening tool called the Hunger Vital Sign.
  • People who speak English.
  • People aged 18 or older.
  • People with a body mass index (a measure of body weight relative to height) of 23 or above.
  • People who do not plan to move away from the local area for at least one year.
  • People who have enough control over their own daily eating to participate in a diet-related study.
  • People who are willing and able to give written consent and take part in all study activities.

Who may not be able to join:

  • People who have taken part in a diabetes, nutrition, or weight-loss research study in the past 12 months.
  • People who currently have an AIDS-defining illness (a serious illness that occurs when HIV has severely weakened the immune system).
  • People who live in the same household as another person already enrolled in this study — only one person per household may participate.
  • People who are planning to have weight-loss (bariatric) surgery in the next year, or who have had that type of surgery in the past two years.
  • People who do not have a safe, stable place to live or somewhere to store meals.
  • People who do not have access to a telephone.
  • People who are currently pregnant, breastfeeding, or planning to become pregnant in the next year.
  • People with a history of cancer — except certain skin cancers, early-stage prostate cancer, or breast cancer found through routine screening — unless the cancer was fully treated more than 5 years ago or is in remission. (confirm with trial site)
  • People with advanced kidney disease, specifically where the kidneys are working at a very low level (confirm with trial site for exact threshold).
  • People with a known problem with drug or alcohol misuse in the past 6 months.
  • People with a known serious mental health condition that would prevent them from taking part in study activities.
  • People who use certain medications — such as steroid tablets or infusions — that can affect blood sugar levels, but only on an irregular or occasional basis (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Seth A Berkowitz, MD, MPH, University of North Carolina, Chapel Hill

Phone: 919-843-6637

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 October 2021
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Bodyweight at Month 6

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov